My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap
1. Is Transchem Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Transchem Ltd is a average quality company.
2. Is Transchem Ltd undervalued or overvalued?
The key valuation ratios of Transchem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Transchem Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |||
| ROCE % ⓘ | -1.6% | 0.3% | -2.9% | -3.4% | -4.9% | 0.4% | 1.1% | 48.5% | 4.4% | 1.9% | - | ||
| Value Creation Index ⓘ | -1.1 | -1.0 | -1.2 | -1.2 | -1.4 | -1.0 | -0.9 | 2.5 | -0.7 | -0.9 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.5 | 0 | 0 | 0 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | -100% | NA | - | ||
| Adj EPS ⓘ | -0.6 | 0.1 | -0.9 | -1.1 | -1.5 | 0.1 | 0.3 | 19.7 | 2.3 | 1 | 1.2 | ||
| YoY Gr. Rt. % | - | NA | -1010% | NA | NA | NA | 135.7% | 5878.8% | -88.1% | -56.8% | - | ||
| BVPS (₹) ⓘ | 31.2 | 31.3 | 31.4 | 31 | 30.1 | 31 | 30 | 51.4 | 54.2 | 53.8 | 54.5 | ||
| Adj Net Profit ⓘ | -0.7 | 0.1 | -1.1 | -1.3 | -1.8 | 0.2 | 0.4 | 24.2 | 2.9 | 1.2 | 2 | ||
| Cash Flow from Ops. ⓘ | 0.6 | 0.9 | 1.1 | 0.6 | -19.8 | 10.3 | -0.6 | -27.7 | 21.9 | 1.2 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | NA | NA | NA | ||||||||
| Adj EPS ⓘ | NA | NA | 45.2% | -56.8% | ||||||||
| BVPSⓘ | 6.2% | 12.3% | 21.4% | -0.7% | ||||||||
| Share Price | 2.7% | -1.9% | 18.3% | -17.7% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | ||
| Return on Equity % ⓘ | -1.8 | 0.3 | -2.9 | -3.4 | -4.9 | 0.4 | 1.1 | 48.5 | 4.4 | 1.9 | 2.3 | |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91.4 | 0 | 0 | NAN | |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107.5 | 0 | 0 | INF | |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 457 | 0 | 0 | 0 | |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Net Profit is growing at healthy rate in last 3 years 45.19%
Return on Equity has declined versus last 3 years average to 2.30%
Sales growth has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 1.2 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 54.5 | - |
| Reserves (₹ Cr.) ⓘ | 54 | - |
| P/BV ⓘ | 0.43 | - |
| PE ⓘ | 18.96 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 15.75 / 34.75 |
| All Time Low / High (₹) | 2.55 / 95.00 |
| Market Cap (₹ Cr.) | 28.9 |
| Equity (₹ Cr.) | 12.2 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 24.9 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.
The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.
The company is having four state of the art GMP approved facilities at multiple locations in
The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.
Products and services offered by the company:
Services:
Product:
Anthelmintics
Veterinary API's
Ectoparaciticides
Human Use API's
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Download APP
